aterosklerozАтеросклерозAteroscleroz2078-256X2949-3633НИИТПМ-филиал ИЦиГ СО РАН10.15372/ATER20170405ateroskleroz-58Research ArticleОБЗОРЫREVIEWSЛИПИДЫ КРОВИ И ПОЛИФЕНОЛЬНЫЕ СОЕДИНЕНИЯ ПИЩЕВОГО РАЦИОНА (обзор литературы, часть 1)BLOOD LIPID AND POLYPHENOL COMPOUND DIETБерезовиковаИ. П.BerezovikovaI. P.ira_ber@mail.ruДенисоваД. В.DenisovaD. V.noemail@neicon.ruБатлукТ. И.BaltukT. I.noemail@neicon.ruВоеводаМ. И.VoevodaM. I.noemail@neicon.ruНИИТПМ - филиал ИЦиГ СО РАНРоссияInstitute of Internal and Preventive Medicine - Branch of Federal Research Institute of Cytology and Genetics of SB RASRussian Federation2017270920191343237Copyright © Березовикова И.П., Денисова Д.В., Батлук Т.И., Воевода М.И., 20192019Березовикова И.П., Денисова Д.В., Батлук Т.И., Воевода М.И.Berezovikova I.P., Denisova D.V., Baltuk T.I., Voevoda M.I.This work is licensed under a Creative Commons Attribution 4.0 License.https://ateroskleroz.elpub.ru/jour/article/view/58

В обзоре систематизированы результаты исследований по влиянию потребления полифенольных соединений на липиды сыворотки крови. Приводятся данные о воздействии содержания полифенолов в различных продуктах, потреблении в разных регионах. Показаны результаты влияния на липидный профиль фенольных кислот какао, ресвератрола, полифенолов оливкового масла. Рассмотрены механизмы воздействия полифенолов на липиды.

The review systematizes the results of studies on the effect of consumption of polyphenolic compounds on serum lipids. Data on the effect of polyphenol content in various products, consumption in different regions are given. The results of the effect on the lipid profile of phenolic acids cocoa, resveratrol, polyphenols olive oil. The mechanisms of the effect of polyphenols on lipids are given.

полифенольные соединениялипиды кровиресвератролтирозолфенольные кислотыисточникипотреблениемеханизм гиполипидемического действияpolyphenolic compoundsblood lipidsresveratroltyrosolphenolic acidssourcesintakemechanism of lipid-lowering actionReferencesSpencer J.P.E., Crozier A., Packer L. et al. Flavonoids, Related Compounds: Bioavailability, Function // Oxidative Stress and Disease. Vol. 30. BocaRaton, FL: CRC Press, 2012.Spencer J.P.E., Crozier A., Packer L. et al. Flavonoids, Related Compounds: Bioavailability, Function // Oxidative Stress and Disease. Vol. 30. BocaRaton, FL: CRC Press, 2012.Daniele Del Rio, Ana Rodriguez-Mateos, Jeremy P.E. Spencer et al. Dietary. (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases // Antioxid. Redox. Signal. 2013. Vol. 18 (14). P. 1818-1892.Daniele Del Rio, Ana Rodriguez-Mateos, Jeremy P.E. Spencer et al. Dietary. (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases // Antioxid. Redox. Signal. 2013. Vol. 18 (14). P. 1818-1892.D’Archivio M., Filesi C., di Benedetto R. et al. Polyphenols, dietary sources and bioavailability // Ann. Ist. Super Sanitа. 2007. Vol. 43, N 4. P. 348-361.D’Archivio M., Filesi C., di Benedetto R. et al. Polyphenols, dietary sources and bioavailability // Ann. Ist. Super Sanitа. 2007. Vol. 43, N 4. P. 348-361.Pietta P., Minoggio M., Bramati L. Plant polyphenols: structure, occurrence and bioactivity // Stud. Nat. Pro. Chem. 2003. Vol. 28: P. 257-312.Pietta P., Minoggio M., Bramati L. Plant polyphenols: structure, occurrence and bioactivity // Stud. Nat. Pro. Chem. 2003. Vol. 28: P. 257-312.Manach C., Scalbert A., Morand C. et al. Polyphenols: food sources and bioavailability // Am. J. Clin. Nutr. 2004. Vol. 79. P. 727-747.Manach C., Scalbert A., Morand C. et al. Polyphenols: food sources and bioavailability // Am. J. Clin. Nutr. 2004. Vol. 79. P. 727-747.http://phenol-explorer.eu (vers. 3.6).http://phenol-explorer.eu (vers. 3.6).Brat P., Georgé S., Bellamy A. et al. Daily polyphenol intake in France from fruit and vegetables // J. Nutr. 2006. Vol. 136, N 9. P. 2368-2373.Brat P., Georgé S., Bellamy A. et al. Daily polyphenol intake in France from fruit and vegetables // J. Nutr. 2006. Vol. 136, N 9. P. 2368-2373.Julia C., Touvier M., Lassale C. et al. Cluster analysis of polyphenol intake in a French middle-aged population (aged 35-64 years) // J. Nutr. Sci. 2016. Vol. 5, article e28.Julia C., Touvier M., Lassale C. et al. Cluster analysis of polyphenol intake in a French middle-aged population (aged 35-64 years) // J. Nutr. Sci. 2016. Vol. 5, article e28.Tresserra-Rimbau A., Guasch-Ferre M., Salas-Salvadoetal J. Intake of total polyphenols and some classes of polyphenols is inversely associated with diabetes in elderly people at high cardiovascular disease risk // J. Nutr. 2016. Vol. 146, N 4. P. 767-777.Tresserra-Rimbau A., Guasch-Ferre M., Salas-Salvadoetal J. Intake of total polyphenols and some classes of polyphenols is inversely associated with diabetes in elderly people at high cardiovascular disease risk // J. Nutr. 2016. Vol. 146, N 4. P. 767-777.Godos J., Marventano S., Mistretta A. et al. Dietary sources of polyphenols in the Mediterranean healthy eating, aging and lifestyle (MEAL) study cohort // Int. J. Food Sci. Nutr. 2017. Vol. 68. P. 750-756.Godos J., Marventano S., Mistretta A. et al. Dietary sources of polyphenols in the Mediterranean healthy eating, aging and lifestyle (MEAL) study cohort // Int. J. Food Sci. Nutr. 2017. Vol. 68. P. 750-756.Vitale M., Vaccaro O., Masulli M. et al. Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: the TOSCA.IT study // Clin. Nutr. 2016. Vol. 36, N 6. P. 1686-1692.Vitale M., Vaccaro O., Masulli M. et al. Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: the TOSCA.IT study // Clin. Nutr. 2016. Vol. 36, N 6. P. 1686-1692.Ovaskainen M.-L., Törrönen R., Koponen J.M. et al. Dietary intake and major food sources of polyphenols in Finnish adults // J. Nutr. 2008. Vol. 138, N 3. P. 562-566.Ovaskainen M.-L., Törrönen R., Koponen J.M. et al. Dietary intake and major food sources of polyphenols in Finnish adults // J. Nutr. 2008. Vol. 138, N 3. P. 562-566.Nascimento-Souza M.A., de Paiva P.G., Pérez-Jiménez J. et al. Estimated dietary intake and major food sources of polyphenols in elderly of Viçosa, Brazil: a population-based study // Eur. J. Nutr. 2016. Nov. 21. [Epubahead of print].Nascimento-Souza M.A., de Paiva P.G., Pérez-Jiménez J. et al. Estimated dietary intake and major food sources of polyphenols in elderly of Viçosa, Brazil: a population-based study // Eur. J. Nutr. 2016. Nov. 21. [Epubahead of print].Taguchi C., Fukushima Y., Kishimoto Y. et al. Estimated dietary polyphenol intake and major food and beverage sources among elderly Japanese // Nutrients. 2015. Vol. 7, N 12. P. 10269-10281.Taguchi C., Fukushima Y., Kishimoto Y. et al. Estimated dietary polyphenol intake and major food and beverage sources among elderly Japanese // Nutrients. 2015. Vol. 7, N 12. P. 10269-10281.Grassi D., Necozione S., Lippi C. et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium dependent vasodilation in hypertensives // Hypertension. 2005. Vol. 46, N 2. P. 398-405.Grassi D., Necozione S., Lippi C. et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium dependent vasodilation in hypertensives // Hypertension. 2005. Vol. 46, N 2. P. 398-405.Shrime M.G., Bauer S.R., McDonald A.C. et al. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies // J. Nutr. 2011. Vol. 141, N 11. P. 1982-1988.Shrime M.G., Bauer S.R., McDonald A.C. et al. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies // J. Nutr. 2011. Vol. 141, N 11. P. 1982-1988.Mellor D.D., Sathyapalan T., Kilpatrick E.S. et al. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in type 2 diabetes patients // Diabet Med. 2010. Vol. 27, N 11. P. 1318-1321.Mellor D.D., Sathyapalan T., Kilpatrick E.S. et al. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in type 2 diabetes patients // Diabet Med. 2010. Vol. 27, N 11. P. 1318-1321.Baba S., Natsume M., Yasuda A. et al. Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normo- and hypercholesterolemic humans after intake of different levels of cocoa powder // J. Nutr. 2007. Vol. 137, N 6. P. 1436-1441.Baba S., Natsume M., Yasuda A. et al. Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normo- and hypercholesterolemic humans after intake of different levels of cocoa powder // J. Nutr. 2007. Vol. 137, N 6. P. 1436-1441.Baba S., Osakabe N., Kato Y. et al. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans // Am. J. Clin. Nutr. 2007. Vol. 85, N 3. P. 709-717.Baba S., Osakabe N., Kato Y. et al. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans // Am. J. Clin. Nutr. 2007. Vol. 85, N 3. P. 709-717.Kris-Etherton P.M., Derr J.A., Mustad V.A. et al. Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA step 1 diet // Am. J. Clin. Nutr. 1994. Vol. 60. N 6 (Suppl). P. 1037S-1042S.Kris-Etherton P.M., Derr J.A., Mustad V.A. et al. Effects of a milk chocolate bar per day substituted for a high-carbohydrate snack in young men on an NCEP/AHA step 1 diet // Am. J. Clin. Nutr. 1994. Vol. 60. N 6 (Suppl). P. 1037S-1042S.Mursu J., Voutilainen S., Nurmi T. et al. Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans // Free. Radic. Biol. Med. 2004. Vol. 37, N 9. P. 1351-1359.Mursu J., Voutilainen S., Nurmi T. et al. Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans // Free. Radic. Biol. Med. 2004. Vol. 37, N 9. P. 1351-1359.Engler M.B., Engler M.M., Chen C.Y. et al. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults // J. Am. Coll. Nutr. 2004. Vol. 23, N 3. P. 197-204.Engler M.B., Engler M.M., Chen C.Y. et al. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults // J. Am. Coll. Nutr. 2004. Vol. 23, N 3. P. 197-204.Almoosawi S., Fyfe L., Ho C. et al. The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects // Br. J. Nutr. 2010. Vol. 103, N 6. P. 842-850.Almoosawi S., Fyfe L., Ho C. et al. The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects // Br. J. Nutr. 2010. Vol. 103, N 6. P. 842-850.Crews W.D. Jr., Harrison D.W., Wright J.W. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults // Am. J. Clin. Nutr. 2008. Vol. 87, N 4. P. 872-880.Crews W.D. Jr., Harrison D.W., Wright J.W. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults // Am. J. Clin. Nutr. 2008. Vol. 87, N 4. P. 872-880.Muniyappa R., Hall G., Kolodziej T.L. et al. Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension // Am. J. Clin. Nutr. 2008. Vol. 88, N 6. P. 1685-1696.Muniyappa R., Hall G., Kolodziej T.L. et al. Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension // Am. J. Clin. Nutr. 2008. Vol. 88, N 6. P. 1685-1696.Magrone T., Russo M.A., Jirillo E. Cocoa and Dark Chocolate Polyphenols: From Biology to Clinical Applications // Front. Immunol. 09 June 2017. https://doi.org/10.3389/fimmu.2017.00677.Magrone T., Russo M.A., Jirillo E. Cocoa and Dark Chocolate Polyphenols: From Biology to Clinical Applications // Front. Immunol. 09 June 2017. https://doi.org/10.3389/fimmu.2017.00677.Tunstall-Pedoe H., Kuulasmaa K., Mahonen M. et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease // Lancet. 1999. Vol. 353. P. 1547-1557.Tunstall-Pedoe H., Kuulasmaa K., Mahonen M. et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease // Lancet. 1999. Vol. 353. P. 1547-1557.Burns J., Yokota T., Ashihara H. et al. Plant foods and herbal sources of resveratrol // J. Agric. Food Chem., 2002. Vol. 50. P. 3337-3340.Burns J., Yokota T., Ashihara H. et al. Plant foods and herbal sources of resveratrol // J. Agric. Food Chem., 2002. Vol. 50. P. 3337-3340.Abdelouahed K., Berrougui H. Mechanism of action of resveratrol in lipid metabolism and atherosclerosis // Clin. Lipidol. 2009. Vol. 4, N 5. P. 527-531.Abdelouahed K., Berrougui H. Mechanism of action of resveratrol in lipid metabolism and atherosclerosis // Clin. Lipidol. 2009. Vol. 4, N 5. P. 527-531.Smoliga J.M., Baur J.A., Hausenblas H.A. Resveratrol and health-A comprehensive review of human clinical trials // Mol. Nutr. Food Res. 2011. Vol. 55. P. 1129-1141.Smoliga J.M., Baur J.A., Hausenblas H.A. Resveratrol and health-A comprehensive review of human clinical trials // Mol. Nutr. Food Res. 2011. Vol. 55. P. 1129-1141.Magyar K., Halmosi R., Palfi A. et al. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease // Clin. Hemorheol. Microcirc. 2012. Vol. 50. P. 179-187.Magyar K., Halmosi R., Palfi A. et al. Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease // Clin. Hemorheol. Microcirc. 2012. Vol. 50. P. 179-187.Troen B.R. Resveratrol: Effects on Lipids and Cardiovascular Risk Article in Current Cardiovascular Risk Reports // February. 2013. DOI: 10.1007/s12170-012-0289.Troen B.R. Resveratrol: Effects on Lipids and Cardiovascular Risk Article in Current Cardiovascular Risk Reports // February. 2013. DOI: 10.1007/s12170-012-0289.Ramprasath V.R., Jones P.J.H. Anti-atherogenic effects of resveratrol // Eur. J. Clin. Nutr. 2010. Vol. 64. P. 660-668.Ramprasath V.R., Jones P.J.H. Anti-atherogenic effects of resveratrol // Eur. J. Clin. Nutr. 2010. Vol. 64. P. 660-668.Tresserra-Rimbau A., Medina-Remon A., Perez-Jimenez J. Dietary intake and major food sourses of polyphenols in Spanish population at high cardiovascular risk: The PREDIMED study // Nutr. Metab. Cardiovasc. Dis. 2013. Vol. 23. P. 953-959.Tresserra-Rimbau A., Medina-Remon A., Perez-Jimenez J. Dietary intake and major food sourses of polyphenols in Spanish population at high cardiovascular risk: The PREDIMED study // Nutr. Metab. Cardiovasc. Dis. 2013. Vol. 23. P. 953-959.Visioli F., Galli C. Biological properties of olive oil phytochemicals // Crit. Rev. Food Sci. Nutr. 2002. Vol. 42. P. 209-221.Visioli F., Galli C. Biological properties of olive oil phytochemicals // Crit. Rev. Food Sci. Nutr. 2002. Vol. 42. P. 209-221.Damasceno N.R.T., A. Serra M., Cofan M. et al. Crossover study of diets enriched with virgin olive oil, walnuts or almonds. Effects on lipids and other cardiovascular risk markers // Nutr. Metab. Cardiovasc. Dis. 2011. Vol. 21. P. S14-S20.Damasceno N.R.T., A. Serra M., Cofan M. et al. Crossover study of diets enriched with virgin olive oil, walnuts or almonds. Effects on lipids and other cardiovascular risk markers // Nutr. Metab. Cardiovasc. Dis. 2011. Vol. 21. P. S14-S20.Covas M., Nyyssönen K., Poulsen H. The effect of polyphenols in olive oil on heart disease risk factors // Ann. Intern. Med. 2006. Vol. 145. P. 333-341.Covas M., Nyyssönen K., Poulsen H. The effect of polyphenols in olive oil on heart disease risk factors // Ann. Intern. Med. 2006. Vol. 145. P. 333-341.Weinbrenner T., Fito M., de la Torre R. et al. Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men // J. Nutr. 2004. Vol. 134. P. 2314-2321.Weinbrenner T., Fito M., de la Torre R. et al. Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men // J. Nutr. 2004. Vol. 134. P. 2314-2321.Kafatos A.G., Zampelas A. Olive oil intake in relation to cardiovascular diseases // Grasas Y Aceites. 2004. Vol. 55. P. 24-32.Kafatos A.G., Zampelas A. Olive oil intake in relation to cardiovascular diseases // Grasas Y Aceites. 2004. Vol. 55. P. 24-32.Hern A., Remaley A.T., Farras M. et. al. Olive Oil Polyphenols Decrease LDL Concentrations and LDL Atherogenicity in Men in a Randomized Controlled Trial // J. Nutr. 2015. First published ahead of print July 1, 2015 as doi: 10.3945/jn.115.211557.Hern A., Remaley A.T., Farras M. et. al. Olive Oil Polyphenols Decrease LDL Concentrations and LDL Atherogenicity in Men in a Randomized Controlled Trial // J. Nutr. 2015. First published ahead of print July 1, 2015 as doi: 10.3945/jn.115.211557.

The authors declare that there are no conflicts of interest present.